Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the commercial launch of Philips NightBalance, a prescription sleep position therapy device designed for patients with positional obstructive sleep apnea (OSA).
The first Health Information Exchange (HIE) in the Middle East, Malaffi, went live at the end of July just six months after contracts were signed between the project company, Abu Dhabi Health Data Services (ADHDS), and technology provider Orion Health.
The availability of appropriate decision support tools for healthcare practitioners can promote uptake of personalised medicine in health care. There is a need to carry out research activities aiming to develop and validate such decision tools that would integrate available and/or emerging diagnostic means for the area concerned, enabling increased precision of diagnostics and clinical decision making.
| Location: | Zug, Rotkreuz, Switzerland |
| Job Type: | Full-Time |
| Employer: | Roche |
Commenting on findings and recommendations from Public Health England's review into dependence and withdrawal associated with some prescribed medicines, Darren Nichols, UK managing director, FDB (First Databank), said:
Abbott (NYSE: ABT) announced that new research, published in the journal Circulation, found its algorithm could help doctors in hospital emergency rooms more accurately determine if someone is having a heart attack or not, so that they can receive faster treatments or be safely discharged.
18 - 21 November 2019, Düsseldorf, Germany.
Opinion Article by Shane Tickell, Chief Executive, IMS MAXIMS